Article
Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma.
Clinical lung cancer - 1 Sept 2013
Tomonaga Nanae, Nakamura Yoichi, Yamaguchi Hiroyuki, Ikeda Takaya, Mizoguchi Kosuke, Motoshima Kohei, Doi Seiji, Nakatomi Katsumi, Iida Tetsuya, Hayashi Tomayoshi, Nagayasu Takeshi, Tsukamoto Kazuhiro, Kohno Shigeru
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor mutations are predictive of the success of EGFR tyrosine kinase inhibitor treatment in patients with advanced non--small-cell lung cancer. As with other solid tumors, lung cancer is thought to be the result of an accumulation of genetic alterations aft...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
